← Leaderboards
Brian R McNaughton
Colorado State University
$1,248,279
Attributed
$1,388,950
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $562.4K · FY2014–17$1M$750K$500K$250K$0
'14
'15
'16
'17
Funding mix
By agency
NIH$1,388,950 · 2
By mechanism
R01$1,388,950 · 2
Top collaborators
- Joseph E Wedekind1 shared
Most similar at Colorado State University
Same institution · by research overlap
- Robert Cohen$5,923,066
- Chaoping Chen$2,322,879
- Michio Kurosu$3,736,561
- Tingting Yao$3,412,805
- Christopher Davis Snow$2,405,350
Others in their field
Top investigators on “Play”
- Lawrence Corey · Fred Hutchinson Cancer Center$428,785,907
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Jeffrey P Krischer · University Of South Florida$191,869,794
- Constance Ann Benson · University Of California, San Diego$187,132,366
Research focus
PlayRna SplicingLeadPharmaceutical PreparationsReagentRna Recognition MotifDrug TargetingIn VivoDrug DiscoveryNucleotidesProtein Protein InteractionProteinsExhibitsEvolutionBinding ProteinsAffinityHiv-1CellsComplexDesignCalorimetryBasePropertySmall Molecule
Grant awards (6)
Cyclic Peptide Inhibitors of HIV-1 Proliferation$281,342
R01 · FY2017 · GM · contact PI
Identification of Protein Drug Leads That Address Challenges to Small Molecule Ce$281,034
R01 · FY2017 · GM · contact PI
Identification of Protein Drug Leads That Address Challenges to Small Molecule Ce$279,961
R01 · FY2016 · GM · contact PI
Identification of Protein Drug Leads That Address Challenges to Small Molecule Ce$255,806
R01 · FY2015 · GM · contact PI
Identification of Protein Drug Leads That Address Challenges to Small Molecule Ce$19,031
R01 · FY2015 · GM · contact PI
Identification of Protein Drug Leads That Address Challenges to Small Molecule Ce$271,776
R01 · FY2014 · GM · contact PI